openPR Logo
Press release

Psoriatic Arthritis Treatment Market to Exhibit 9.5% CAGR and Reach $13.12 Billion: Advanced Predictive Analytics offered by RCM to Boost Growth

03-30-2022 08:53 AM CET | Health & Medicine

Press release from: Fortune Business Insights

Psoriatic Arthritis Treatment Market

Psoriatic Arthritis Treatment Market

The global psoriatic arthritis treatment market size is anticipated to touch USD 13.12 billion by the end of 2027 on account of the increasing prevalence of psoriatic arthritis. According to a published report by Fortune Business Insights titled, "Psoriatic Arthritis Treatment Market Size, Share & COVID-19 Impact Analysis, By Drugs Class (Non-steroidal Anti-inflammatory Drugs (NSAIDS), Non-biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs), Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Forecast, 2020-2027," the value of this market was USD 6.35 billion in the year 2019. The forecast period is set between 2020 and 2027 and the market is expected to rise at a CAGR of 9.5%.

Get Sample PDF Brochure:
https://www.fortunebusinessinsights.com/enquiry/sample/psoriatic-arthritis-treatment-market-101066

Most of the businesses today are affected by the coronavirus pandemic. The imposition of stringent government regulations for controlling the widespread use of this virus has majorly impacted the world economy. Some of the businesses that are operating from homes are barely able to generate meagre revenue.
Fortune Business Insights is offering detailed analysis on the impact of the COVID-19 pandemic on different markets. These reports will assist financers and other candidates to study the current situation and accordingly plan ahead of the future.

Geographical Analysis:
• North America (The U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
• Latin America (Brazil, Mexico, and the Rest of Latin America)
• The Middle East & Africa (South Africa, GCC, and the Rest of the Middle East & Africa)
What is the Scope of the Report?
The report is based on a qualitative and quantitative analysis of the market and emphasizes mainly on drivers, restraints, challenges, and upcoming opportunities. It also discusses the key industry trends, current developments, and other insights into the market. The report also highlights the list of players operating in the market and their attributed factors. The report is available for sale on the company website.

To get to know more about the short-term and long-term impact of COVID-19 on this market,
Please Visit: https://www.fortunebusinessinsights.com/industry-reports/psoriatic-arthritis-treatment-market-101066

Drivers & Restraints
Rising Prevalence of Psoriasis Arthritis to Augment Growth
The growing geriatric population and the increasing prevalence of psoriatic arthritis are the key factors boosting the global psoriatic arthritis treatment market growth. This disease is likely to prevail in people leading a stressful lifestyle. This, coupled with the increasing affordability of biologic products and new product launches, will also contribute positively to the growth of the market.

On the negative side, the impact of the COVID-19 pandemic has reduced the urgency of other diseases and therefore hampered the growth of the market for psoriatic arthritis. Moreover, the high cost of biologic products used for treating this kind of disease may pose a major challenge to the growth of this market.

Nevertheless, the continuously rising patient pool and the increasing preference for the use of biological treatment products especially by dermatologists are likely to create lucrative growth opportunities for the market in the coming years.

Segmentation-
DMARDs Segment to Dominate Market Owing to Increasing Adoption of Biological Therapies
Among all drug class types, the biologic disease modifying anti-rheumatic drugs (DMARDs) segment earned the largest psoriatic arthritis treatment market share in 2019. This is accountable to the increasing adoption of biological therapies, a factor that is attributable to its efficacy towards disease management.

Speak To Our Analyst:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/psoriatic-arthritis-treatment-market-101066

Regional Analysis-
Rising Adoption of Biological Therapies to help North America Continue Dominating Market
Among all regions, North America accounted for the largest share on account of the massive investments in research and development of therapeutic options and coupled with the increasing adoption of biological therapies to treat psoriasis arthritis. Moreover, the presence of large manufacturers and the continuous number of clinical trials and drug approvals by the U.S. Food and Drug Administration will further help this region dominate the market in the coming years.
Europe ranks second in terms of market size whereas Asia Pacific market is likely to emerge as the fastest growing region in the forecast duration on account of the improving healthcare infrastructure, rise in medical expenditure, and the entry of novel biologics.

Competitive Landscape-
Players Focusing on Getting FDA Approvals of their Products to Stay Ahead in the Competition
The competitive landscape of the global psoriatic arthritis treatment market is consolidated in nature on account of the presence of a few players. Among them, AbbVie is holding the leading position in the market owing to its most popular brand, Humira used for treating psoriatic arthritis. Some of the other players are engaging in launching products and anticipating FDA approvals to gain a competitive edge in the market competition.

Industry Developments
December 2017 - The U.S. Food and Drug Administration permitted the use of Infliximab, an antibody for fighting diseases such as plague psoriasis, ankylosing spondylitis, Crohn's disease, and others.
August 2019 - Otezla was acquired by Amgen for USD 13.4 billion cash. This new therapy will help to strengthen the overall portfolio of Amgen.

List of Companies Profiled in the market for psoriatic arthritis treatment:
• Bayer AG (Leverkusen, Germany)
• Bristol-Myers Squibb Company (New York, United States)
• AstraZeneca (Cambridge, United Kingdom)
• Johnson & Johnson Services, Inc. (New Jersey, United States)
• Pfizer Inc. (New York, United States)
• Eli Lilly and Company (Indiana, United States)
• Novartis AG (Basel, Switzerland)
• GlaxoSmithKline plc. (Brentford, United Kingdom)
• Hoffmann-La Roche Ltd (Basel, Switzerland)
• Amgen (Califormia, United States)
• Sanofi (Paris, France)

Quick Buy - Psoriatic Arthritis Treatment Market Research Report:
https://www.fortunebusinessinsights.com/checkout-page/101066

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
LinkedIn: https://www.linkedin.com/company/fortune-business-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Psoriatic Arthritis Treatment Market to Exhibit 9.5% CAGR and Reach $13.12 Billion: Advanced Predictive Analytics offered by RCM to Boost Growth here

News-ID: 2590594 • Views:

More Releases from Fortune Business Insights

Future of Renewable Energy Market Insights: Growth Drivers, and Regional Developments
Future of Renewable Energy Market Insights: Growth Drivers, and Regional Develop …
Global Renewable Energy Market Overview The global renewable energy market size was valued at USD 954 billion in 2023. The market is projected to grow from USD 1,020.94 billion in 2024 to USD 1,574.17 billion by 2032, exhibiting a CAGR of 5.56% during the forecast period. Asia Pacific dominated the renewable energy market with a market share of 67.76% in 2023. The Renewable energy market in the U.S. is projected to
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
Market Overview The global DC drives market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 9.23 billion by 2032, exhibiting a CAGR of 5.59% during the forecast period of 2019-2032. Asia Pacific dominated the global market with a share of 28.8% in 2018. The DC drives market in the U.S. is projected to grow significantly, reaching an estimated value of USD 1.59 billion by
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Growth
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Grow …
Brief Market Overview: The global humanoid robots market is rapidly transitioning from a nascent field into a major growth sector, with its value escalating from USD 2.43 billion in 2023 to a projected USD 66.0 billion by 2032, demonstrating a remarkable CAGR of 45.5%. These complex machines, which merge mechanical, electrical, and software engineering, are moving beyond research labs into real-world applications across industrial, service, and household sectors. This explosive growth
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by 2032 with a CAGR of 4.5%.
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by …
The global methanol market size was valued at USD 31.26 billion in 2023. It is projected to grow from USD 32.70 billion in 2024 to USD 46.32 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period. The global methanol market size is set to gain traction from the urgent need to lower environmental pollution caused by the surging usage of heavy fuels, such as diesel and gasoline. Pollution

All 5 Releases


More Releases for Arthritis

Rising Arthritis Cases Fueling Market Growth For Rheumatoid Arthritis Drugs: Piv …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Rheumatoid Arthritis Drugs Market Size Growth Forecast: What to Expect by 2025? In recent years, there has been a slight decline in the rheumatoid arthritis drugs market size. It is projected to rise from "$60.3 billion in 2024 to $60.1 billion in 2025, with a compound annual growth rate
Infectious Arthritis (Septic Arthritis) Market Detailed Industry Report Analysis …
Introduction Infectious arthritis, also known as septic arthritis, is a serious joint condition caused by bacterial, viral, or fungal infections that lead to rapid joint destruction if not treated promptly. The disease primarily affects large joints such as the knee and hip but can also impact smaller joints. It is considered a medical emergency requiring rapid diagnosis and treatment with antibiotics or antifungals, often combined with joint drainage or surgical intervention. The
Nooro Arthritis Hand Massager Reviews: Is the Nooro Arthritis Hand Massager Wort …
The Nooro Arthritis Hand Massager is a revolutionary device designed to offer relief to individuals suffering from hand pain, particularly those dealing with conditions such as arthritis, carpal tunnel syndrome, and repetitive strain injuries. As hand pain can significantly impact daily activities, from typing to gripping objects, finding an effective, non-invasive solution is crucial. The Nooro Arthritis Hand Massager provides a gentle yet effective remedy by combining advanced heat therapy
Rheumatoid Arthritis Drug Market Rheumatoid Arthritis Clinical Pipeline Report 2 …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Antirheumatoids: Call of Rheumatoid Arthritis 1.1 Prologue towards Rheumatoid Arthritis 1.2 Obtainable Treatment for Rheumatoid Arthritis Molecular Mechanism of Antirheumatoids 2.1 Purpose of DMARDs in Rheumatoid Arthritis 2.2 Role of Biological Agents in Rheumatoid Arthritis 2.2.1 TNF- Inhibitors 2.2.2 Interleukin -1 and IL-6 Blockers Classification of Rheumatoid Arthritis Drugs 3.1
Rheumatoid Arthritis Treatment Market
Rheumatoid arthritis (RA) is the most common autoimmune arthritis affecting more than 1.3 million U.S. citizens (American College of Rheumatology). More surprising is to know that around 75% of this affected population is women. Affecting the joints at any age, rheumatoid arthritis needs to be addressed early to avoid expensive joint replacement surgery. While it can affect any joint, small joints in hand and feet tend to be affected the
Worldwide Arthritis - EpiCast Report: Rheumatoid Arthritis - Epidemiology Foreca …
"EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2025" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- ** Summary Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the bodys immune system attacks the lining of the joints, known as